Embryonic, Fetal, and Neonatal Complications in Infants of Diabetic Mothers: Insights from the Cincinnati Diabetes in Pregnancy Program Project Grant
American Journal of Perinatology · 01.03.2025 · 42 (04) · 420-427
DOI: 10.1055/a-2382-7397 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Perinatology, erschienen am 01.03.2025. Verfasst von Francis B Mimouni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Research Institute, Leumit Health Services, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Pregnancy in Diabetics, Congenital Abnormalities, Diabetes, Gestational, Infant, Newborn, Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: CLC NIH HHS, U.S. Department of Health and Human Services, National Institutes of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study aimed to review how the Cincinnati Diabetes in Pregnancy Program Project Grant (PPG) contributed to the understanding and treatment of neonatal complications in infants of diabetic mothers (IDMs). This is a retrospective review of all PPG work on glycemic control at different pregnancy time points and its association with embryonic, fetal, and neonatal complications, such as congenital malformations (CMs), intrauterine growth restriction, macrosomia, hypoglycemia, respiratory distress syndrome (RDS), asphyxia, and polycythemia. We found that maternal vasculopathy and poor glycemic control during embryogenesis, but not frequency of maternal hypoglycemic episodes or insulin therapy, are independent risk factors for major CMs. A suggestive association of major CMs with maternal Magnesium deficiency was also observed. Poor glycemic control during late embryogenesis and early fetal development was associated with an increased risk of minor CMs. We described a biphasic pattern of fetal growth whereby early growth delay was followed by enhanced fetal growth associated with neonatal macrosomia. Macrosomia was associated with poorer glycemic control in the third trimester and an increased risk of birth trauma. Macrosomia was also correlated with animal-origin insulin concentrations in cord blood, demonstrating that insulin bound to antibodies can cross the placenta and may affect the fetus. We also showed that neonatal hypoglycemia was significantly associated with third-trimester glycemic control, in addition to hyperglycemia occurring during labor. With modern management and adequate prenatal care, IDMs are no longer at increased risk for RDS. Perinatal asphyxia was associated with increased proteinuria appearing in pregnancy, maternal hyperglycemia before delivery, and prematurity. Polycythemia in IDMs is prevalent and correlates with proxy measurements of fetal hypoxemia (nucleated red blood cells at delivery) and poorer glycemic control in late pregnancy. The PPG in its various phases revealed the important role of glycemic control at nearly every stage of pregnancy including labor. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Research Institute, Leumit Health Services, and the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
- Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
- Department of Environmental and Public Health Sciences, University of Cincinnati, College of Medicine, Cincinnati, Ohio.
- Department of Obstetrics and Gynecology, Jersey City Medical Center, Jersey City, New Jersey.
Förderung
- CLC NIH HHS
- U.S. Department of Health and Human Services
- National Institutes of Health
- Clinical Center
- HD 11725 Diabetes in Pregnancy
Zitieren
APA
Mimouni, F. B., Khoury, J. C., Ehrlich, S., Rosenn, B. M., Sheffer-Mimouni, G., & Miodovnik, M. (2025). Embryonic, Fetal, and Neonatal Complications in Infants of Diabetic Mothers: Insights from the Cincinnati Diabetes in Pregnancy Program Project Grant. American Journal of Perinatology, 42(04), 420-427. https://doi.org/10.1055/a-2382-7397
Vancouver
Mimouni FB, Khoury JC, Ehrlich S, Rosenn BM, Sheffer-Mimouni G, Miodovnik M. Embryonic, Fetal, and Neonatal Complications in Infants of Diabetic Mothers: Insights from the Cincinnati Diabetes in Pregnancy Program Project Grant. American Journal of Perinatology. 2025;42(04):420-427. doi:10.1055/a-2382-7397
BibTeX
@article{Mimouni2025,
author = {Mimouni, Francis B and Khoury, Jane C and Ehrlich, Shelley and Rosenn, Barak M and Sheffer-Mimouni, Galit and Miodovnik, Menachem},
title = {Embryonic, Fetal, and Neonatal Complications in Infants of Diabetic Mothers: Insights from the Cincinnati Diabetes in Pregnancy Program Project Grant},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {04},
pages = {420--427},
doi = {10.1055/a-2382-7397}
}
EUVIMED